Article Details

Synthorx Announces $63 Million Series C Financing to Advance a Pipeline of SynthorinT Cytokines

Retrieved on: 2018-04-29 20:22:30

Tags for this article:

Click the tags to see associated articles and topics

Synthorx Announces $63 Million Series C Financing to Advance a Pipeline of SynthorinT Cytokines. View article details on hiswai:

Excerpt

<div>Partners, and existing investors, <b>Avalon Ventures</b>, RA Capital. Management, and Correlation Ventures. In addition, Peter Thompson,. M.D., private equity partner at OrbiMed, and Vickie Capps, an. independent advisor with extensive financial and audit experience,. will join the Synthorx board of directors.</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up